BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38630325)

  • 1. Chlordiazepoxide against signalling, receptor and regulatory proteins of breast cancer: a structure-based in-silico approach.
    Alsaiari AA; Gharib AF; Bakhuraysah MM; Alrehaili AA; Algethami SM; Alsaif HA; Al Harthi N; Hakami MA
    Med Oncol; 2024 Apr; 41(5):117. PubMed ID: 38630325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor.
    Almasoudi HH; Mashraqi MM; Alshamrani SA; Alharthi AA; Alsalmi O; Nahari MH; Al-Mansour FSH; Alhazmi AYM
    Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based multitargeted docking screening, pharmacokinetics, DFT, and dynamics simulation studies reveal mitoglitazone as a potent inhibitor of cellular survival and stress response proteins of lung cancer.
    Binshaya AS; Alkahtani OS; Aldakheel FM; Hjazi A; Almasoudi HH
    Med Oncol; 2024 Mar; 41(5):101. PubMed ID: 38546811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid's Adroit Activity against Lung Cancer through Multitargeted Docking, MM\GBSA, QM-DFT and Multiscale Simulations.
    Hakami MA; Hazazi A; Albloui F; Gharib AF; Alsaeedi FA; Abdulaziz O; Alhazmi AY; Alsaiari AA
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisampling-based docking reveals Imidazolidinyl urea as a multitargeted inhibitor for lung cancer: an optimisation followed multi-simulation and
    Ahmad S; Singh V; Gautam HK; Raza K
    J Biomol Struct Dyn; 2024 Mar; 42(5):2494-2511. PubMed ID: 37154501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineating Pixantrone Maleate's adroit activity against cervical cancer proteins through multitargeted docking-based MM\GBSA, QM-DFT and MD simulation.
    Almasoudi HH; Nahari MH; Alhazmi AYM; Almasabi SHA; Al-Mansour FSH; Hakami MA
    PLoS One; 2023; 18(12):e0295714. PubMed ID: 38100507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multitargeted inhibitory effect of Mitoxantrone 2HCl on cervical cancer cell cycle regulatory proteins: a multitargeted docking-based MM\GBSA and MD simulation study.
    Alshehri MA; Asiri SA; Alzahrani A; Alazragi RS; Alqahtani LS; Alqosaibi AI; Alnamshan MM; Alam Q; Rafeeq MM
    Med Oncol; 2023 Oct; 40(11):337. PubMed ID: 37864019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitoxantrone 2HCl's adroit activity against cervical cancer replication and maintenance proteins: a multitargeted approach.
    Hakami MA; Hazazi A; Alsulami MO; Alsaiari AA
    J Biomol Struct Dyn; 2024 Mar; ():1-14. PubMed ID: 38517073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study.
    Almasoudi HH; Hakami MA; Alhazmi AY; Makkawi M; Alasmari S; Alghamdi YS; Mashraqi MM
    Med Oncol; 2023 Jul; 40(8):218. PubMed ID: 37394519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variolin B from sea sponge against lung cancer: a multitargeted molecular docking with fingerprinting and molecular dynamics simulation study.
    Alsalmi O; Mashraqi MM; Alshamrani S; Almasoudi HH; Alharthi AA; Gharib AF
    J Biomol Struct Dyn; 2024 Apr; 42(7):3507-3519. PubMed ID: 37855303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular screening reveals Variolin B as a multitargeted inhibitor of lung cancer: a molecular docking-based fingerprinting and molecular dynamics simulation study.
    Almasoudi HH; Mashraqi MM; Alshamrani S; Alsalmi O; Alharthi AA; Gharib AF
    J Biomol Struct Dyn; 2024; 42(1):11-21. PubMed ID: 37771142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-silico Design, ADMET Screening, MM-GBSA Binding Free Energy of Some Novel Isoxazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer.
    Kalirajan R; Pandiselvi A; Gowramma B; Balachandran P
    Curr Drug Res Rev; 2019; 11(2):118-128. PubMed ID: 31513003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study.
    Ahmad S; Raza K
    Mol Divers; 2023 Apr; ():. PubMed ID: 37058176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.
    Yousif FA; Alzain AA; Alraih AM; Ibraheem W
    PLoS One; 2023; 18(9):e0291256. PubMed ID: 37682937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the multitargeted potency of Sodium Danshensu against cervical cancer: a multitargeted docking-based, structural fingerprinting and molecular dynamics simulation study.
    Alghamdi S; Baeissa HM; Azhar Kamal M; Rafeeq MM; Al Zahrani A; Maslum AA; Hakeem IJ; Alazragi RS; Alam Q
    J Biomol Struct Dyn; 2023 Aug; ():1-13. PubMed ID: 37599470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrazole Substituted 9-Anilinoacridines as HER2 Inhibitors Targeting Breast Cancer - An in-silico approach.
    Rajagopal K; Sri VB; Byran G; Gomathi S
    Curr Drug Res Rev; 2022; 14(1):61-72. PubMed ID: 34139975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of Novel Imidazopyrazine Derivative against Breast Cancer
    Niranjan V; R V; Philip S; Uttarkar A; Kusanur R; Kumar J
    Anticancer Agents Med Chem; 2023; 23(15):1783-1793. PubMed ID: 37151057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical Characterization,
    Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
    Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Bouricha EM; Hakmi M; Akachar J; Zouaidia F; Ibrahimi A
    J Biomol Struct Dyn; 2022 Jul; 40(11):5203-5210. PubMed ID: 33402049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of Iminosugars as Antiviral Agents against SARS-CoV-2 Main Protease: Inhibitor Design and Optimization, Molecular Docking, and Molecular Dynamics Studies to Explore Potential Inhibitory Effect of 1-Deoxynojirmycin Series.
    Miglani V; Sharma P; Kumar Narula A
    Curr Comput Aided Drug Des; 2023 Aug; ():. PubMed ID: 37612857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.